2021 Q4 Form 10-K Financial Statement

#000089772321000028 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $1.644B $6.757B $1.875B
YoY Change -12.32% -2.93% 1.89%
Cost Of Revenue $1.513B $6.205B $1.723B
YoY Change -12.18% -3.57% 1.04%
Gross Profit $130.9M $551.8M $151.9M
YoY Change -13.84% 4.96% 12.62%
Gross Profit Margin 7.96% 8.17% 8.1%
Selling, General & Admin $56.99M $234.5M $56.20M
YoY Change 1.41% -2.65% -11.01%
% of Gross Profit 43.54% 42.5% 37.0%
Research & Development $5.484M $20.91M $6.400M
YoY Change -14.31% -7.33% 23.08%
% of Gross Profit 4.19% 3.79% 4.21%
Depreciation & Amortization $27.45M $109.7M $28.50M
YoY Change -3.68% -3.99% -0.82%
% of Gross Profit 20.97% 19.87% 18.76%
Operating Expenses $62.47M $270.5M $62.60M
YoY Change -0.2% -9.23% -19.43%
Operating Profit $68.41M $281.3M $89.30M
YoY Change -23.4% 23.55% 56.17%
Interest Expense -$4.660M $19.55M -$7.700M
YoY Change -39.48% -32.36% -231.02%
% of Operating Profit -6.81% 6.95% -8.62%
Other Income/Expense, Net -$937.0K $25.71M $2.800M
YoY Change -133.46% -195.45% -165.9%
Pretax Income $69.16M $307.0M $77.10M
YoY Change -10.3% 52.92% 45.66%
Income Tax $12.59M $38.00M $25.50M
% Of Pretax Income 18.21% 12.38% 33.07%
Net Earnings $56.57M $269.0M $51.60M
YoY Change 9.62% 92.54% 34.57%
Net Earnings / Revenue 3.44% 3.98% 2.75%
Basic Earnings Per Share $4.12
Diluted Earnings Per Share $842.1K $4.01 $751.1K
COMMON SHARES
Basic Shares Outstanding 64.38M shares 65.32M shares 65.07M shares
Diluted Shares Outstanding 67.08M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $650.0M $650.0M $481.0M
YoY Change 35.14% 35.28% 11.6%
Cash & Equivalents $650.0M $650.0M $480.5M
Short-Term Investments
Other Short-Term Assets $53.95M $53.95M $38.00M
YoY Change 41.98% 43.11% -15.56%
Inventory $1.037B $1.037B $861.3M
Prepaid Expenses
Receivables $1.541B $1.541B $1.440B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.282B $3.282B $2.819B
YoY Change 16.39% 16.4% 0.51%
LONG-TERM ASSETS
Property, Plant & Equipment $533.0M $601.0M $559.2M
YoY Change -4.7% -1.77% -8.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $157.0M $324.1M $120.5M
YoY Change 30.25% -5.08% -11.04%
Total Long-Term Assets $925.1M $925.1M $953.2M
YoY Change -2.95% -2.96% -6.96%
TOTAL ASSETS
Total Short-Term Assets $3.282B $3.282B $2.819B
Total Long-Term Assets $925.1M $925.1M $953.2M
Total Assets $4.207B $4.207B $3.773B
YoY Change 11.51% 11.5% -1.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.465B $1.465B $1.210B
YoY Change 21.04% 21.05% 2.53%
Accrued Expenses $279.5M $279.5M $294.0M
YoY Change -4.92% -4.85% -5.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $18.75M $18.75M $19.00M
YoY Change -1.32% -0.27% -17.39%
Total Short-Term Liabilities $1.763B $1.763B $1.523B
YoY Change 15.79% 15.79% -0.49%
LONG-TERM LIABILITIES
Long-Term Debt $311.6M $311.6M $329.2M
YoY Change -5.37% -5.35% -3.88%
Other Long-Term Liabilities $253.5M $253.5M $290.9M
YoY Change -12.85% -12.85% 4.76%
Total Long-Term Liabilities $565.1M $565.1M $620.2M
YoY Change -8.88% -8.87% -0.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.763B $1.763B $1.523B
Total Long-Term Liabilities $565.1M $565.1M $620.2M
Total Liabilities $2.328B $2.328B $2.143B
YoY Change 8.65% 8.65% -0.35%
SHAREHOLDERS EQUITY
Retained Earnings -$3.454B -$3.723B
YoY Change -7.22%
Common Stock $6.339B $6.301B
YoY Change 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.047B $983.1M
YoY Change 6.52%
Treasury Stock Shares 44.43M shares 42.63M shares
Shareholders Equity $1.879B $1.879B $1.630B
YoY Change
Total Liabilities & Shareholders Equity $4.207B $4.207B $3.773B
YoY Change 11.51% 11.5% -1.49%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $56.57M $269.0M $51.60M
YoY Change 9.62% 92.54% 34.57%
Depreciation, Depletion And Amortization $27.45M $109.7M $28.50M
YoY Change -3.68% -3.99% -0.82%
Cash From Operating Activities $91.72M $338.3M $79.90M
YoY Change 14.79% 12.57% 277.4%
INVESTING ACTIVITIES
Capital Expenditures -$30.57M $73.30M -$11.20M
YoY Change 172.98% 11.08% -139.93%
Acquisitions $21.41M
YoY Change
Other Investing Activities $84.00K -$18.03M $30.70M
YoY Change -99.73% -1226.81% 7575.0%
Cash From Investing Activities -$30.49M -$91.33M $19.50M
YoY Change -256.36% 41.79% -169.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $64.06M
YoY Change -64.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -34.58M -$77.32M -736.0M
YoY Change -95.3% -63.23% 4133.29%
NET CHANGE
Cash From Operating Activities 91.72M $338.3M 79.90M
Cash From Investing Activities -30.49M -$91.33M 19.50M
Cash From Financing Activities -34.58M -$77.32M -736.0M
Net Change In Cash 26.65M $169.5M -636.6M
YoY Change -104.19% 557.36% 2533.08%
FREE CASH FLOW
Cash From Operating Activities $91.72M $338.3M $79.90M
Capital Expenditures -$30.57M $73.30M -$11.20M
Free Cash Flow $122.3M $265.0M $91.10M
YoY Change 34.24% 12.99% -1425.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000897723
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-10-02
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-02
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
0-21272
CY2021 dei Entity Registrant Name
EntityRegistrantName
Sanmina Corporation
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0228183
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2700 N. First St.,
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
CY2021 dei City Area Code
CityAreaCode
408
CY2021 dei Local Phone Number
LocalPhoneNumber
964-3500
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Trading Symbol
TradingSymbol
SANM
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021Q2 dei Entity Public Float
EntityPublicFloat
1479270225 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64376752 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
650026000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480526000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1036511000 USD
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1192434000 USD
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1043334000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
348741000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
396583000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
861281000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53952000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37718000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3281664000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2819442000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
532985000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559242000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
235117000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
273470000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
156953000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
120502000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1464693000 USD
CY2021Q4 us-gaap Assets
Assets
4206719000 USD
CY2020Q4 us-gaap Assets
Assets
3772656000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1210049000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
161896000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
171761000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
117648000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
122029000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
18750000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
18750000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1762987000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1522589000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
311572000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
329249000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
253532000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
290902000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
565104000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
620151000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
166667000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
166667000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108734000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107629000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64307000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64999000 shares
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
643000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
650000 USD
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
44427000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
42630000 shares
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1047202000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
983143000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6338863000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6300887000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40690000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34886000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3454366000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3723364000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1878628000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1629916000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4206719000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3772656000 USD
CY2021 us-gaap Revenues
Revenues
6756643000 USD
CY2020 us-gaap Revenues
Revenues
6960370000 USD
CY2019 us-gaap Revenues
Revenues
8233859000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6204838000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6434663000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7641921000 USD
CY2021 us-gaap Gross Profit
GrossProfit
551805000 USD
CY2020 us-gaap Gross Profit
GrossProfit
525707000 USD
CY2019 us-gaap Gross Profit
GrossProfit
591938000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
234537000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
240931000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
260032000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20911000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22564000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27552000 USD
CY2021 sanm Restructuring And Other Operating Expense
RestructuringAndOtherOperatingExpense
15057000 USD
CY2020 sanm Restructuring And Other Operating Expense
RestructuringAndOtherOperatingExpense
27916000 USD
CY2019 sanm Restructuring And Other Operating Expense
RestructuringAndOtherOperatingExpense
18237000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6609000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
270505000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
298020000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
305821000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
281300000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
227687000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
286117000 USD
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
925000 USD
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
2322000 USD
CY2019 us-gaap Interest And Other Income
InterestAndOtherIncome
1111000 USD
CY2021 us-gaap Interest Expense
InterestExpense
19551000 USD
CY2020 us-gaap Interest Expense
InterestExpense
28903000 USD
CY2019 us-gaap Interest Expense
InterestExpense
30763000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44331000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-348000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10846000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25705000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26929000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-40498000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
307005000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
200758000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
245619000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38007000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61045000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104104000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268998000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
139713000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
141515000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.05
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.01
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65318000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69041000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69129000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67084000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70793000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71678000 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268998000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
139713000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
141515000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9223000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-925000 USD
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1621000 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
3034000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-3646000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-21508000 USD
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-4863000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1332000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1955000 USD
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-4713000 USD
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
6240000 USD
CY2019 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
11450000 USD
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
2417000 USD
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
2106000 USD
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
939000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5804000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7373000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31685000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
274802000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132340000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
109830000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1472844000 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13539000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30844000 USD
CY2019 sanm Treasury Stock Value Acquired Cost Methodand Adjustmentsto Apic
TreasuryStockValueAcquiredCostMethodandAdjustmentstoAPIC
12614000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34976000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31685000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
141515000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1642573000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7793000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26235000 USD
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
179025000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7373000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
139713000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1629916000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2993000 USD
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
64059000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5804000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268998000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1878628000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268998000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
139713000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
141515000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34976000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13567000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
109656000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114218000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
116949000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
26235000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
30844000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
33724000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
54668000 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8409000 USD
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021 sanm Gain On Sale Of Intellectual Property
GainOnSaleOfIntellectualProperty
15000000 USD
CY2020 sanm Gain On Sale Of Intellectual Property
GainOnSaleOfIntellectualProperty
0 USD
CY2019 sanm Gain On Sale Of Intellectual Property
GainOnSaleOfIntellectualProperty
0 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
8263000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 USD
CY2019 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 USD
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1371000 USD
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-239000 USD
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2219000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
146516000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-83623000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54947000 USD
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-47842000 USD
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
283000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
20814000 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
167186000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39564000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-121383000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6486000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17798000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10018000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
236270000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-106640000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-182521000 USD
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-48302000 USD
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-35410000 USD
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
53757000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
338342000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
300555000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
382965000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73296000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65982000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134674000 USD
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1084000 USD
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1573000 USD
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7532000 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2705000 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
30000000 USD
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
499000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
30000000 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21408000 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021 sanm Proceeds From Sale Of Intellectual Property
ProceedsFromSaleOfIntellectualProperty
5000000 USD
CY2020 sanm Proceeds From Sale Of Intellectual Property
ProceedsFromSaleOfIntellectualProperty
0 USD
CY2019 sanm Proceeds From Sale Of Intellectual Property
ProceedsFromSaleOfIntellectualProperty
0 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91325000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64409000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-127641000 USD
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
399600000 USD
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1909000000 USD
CY2019 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3884325000 USD
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
399600000 USD
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1909000000 USD
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
4099325000 USD
CY2021 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
18752000 USD
CY2020 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
39048000 USD
CY2019 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
378416000 USD
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
375000000 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2727000 USD
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2993000 USD
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7793000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480526000 USD
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13539000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
64059000 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
179025000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12614000 USD
CY2021 sanm Proceeds From Notes Receivable
ProceedsFromNotesReceivable
2500000 USD
CY2020 sanm Proceeds From Notes Receivable
ProceedsFromNotesReceivable
0 USD
CY2019 sanm Proceeds From Notes Receivable
ProceedsFromNotesReceivable
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-77318000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-210280000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-220218000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-199000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-81000 USD
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
107000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
169500000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25785000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35213000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
20477000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
454741000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
419528000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
650026000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480526000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
454741000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15264000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
30143000 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
33358000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
30700000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
32132000 USD
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20929000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
12371000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
27279000 USD
CY2021 sanm Reportable Segment Revenue Percentage
ReportableSegmentRevenuePercentage
0.80
CY2021 us-gaap Fiscal Period
FiscalPeriod
Fiscal Year. The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2021 and 2019 were each 52 weeks and fiscal 2020 was a 53-week year, with the extra week occurring during the fourth quarter of fiscal 2020. All references to years relate to fiscal years unless otherwise noted.
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Estimates and Uncertainties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Due to the COVID-19 pandemic, the global economy and financial markets were disrupted and there is a significant amount of uncertainty about the length and severity of the consequences caused by the pandemic. The Company has considered information available to it as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision to the carrying value of its assets or liabilities. Significant estimates made in preparing the consolidated financial statements relate to allowances for accounts receivable; provisions for excess and obsolete inventories, environmental matters, and legal exposures; determining liabilities for uncertain tax positions; determining the realizability of deferred tax assets; and determining fair values of tangible and intangible assets for purposes of impairment tests. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.</span>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments and Concentration of Credit Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial instruments consist primarily of cash and cash equivalents, accounts receivable, foreign currency forward contracts, interest rate swap agreements, accounts payable and debt obligations. The fair value of these financial instruments approximates their carrying amount as of October 2, 2021 and </span>October 3, 2020 due to the nature or short maturity of these instruments, or because, in some cases, the instruments are recorded at fair value on the consolidated balance sheets.
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9000000 USD
CY2021 sanm Number Of Other Operating Segment Excluding Das
NumberOfOtherOperatingSegmentExcludingDAS
10
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
311572000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
329249000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2247612000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2210521000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1714627000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1651279000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
532985000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559242000 USD
CY2021 us-gaap Depreciation
Depreciation
109000000 USD
CY2020 us-gaap Depreciation
Depreciation
113000000 USD
CY2019 us-gaap Depreciation
Depreciation
115000000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
8000000 USD
CY2021 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
16000000 USD
CY2021 sanm Percentof Net Sales Transferred Over Time
PercentofNetSalesTransferredOverTime
0.95
CY2021Q4 sanm Raw Materials As A Percentage Of Total Inventory
RawMaterialsAsAPercentageOfTotalInventory
0.99
CY2021 sanm Number Of Other Operating Segment Excluding Das
NumberOfOtherOperatingSegmentExcludingDAS
10
CY2021 us-gaap Revenues
Revenues
6756643000 USD
CY2020 us-gaap Revenues
Revenues
6960370000 USD
CY2019 us-gaap Revenues
Revenues
8233859000 USD
CY2021 us-gaap Revenues
Revenues
6756643000 USD
CY2020 us-gaap Revenues
Revenues
6960370000 USD
CY2019 us-gaap Revenues
Revenues
8233859000 USD
CY2021 us-gaap Revenues
Revenues
6756643000 USD
CY2020 us-gaap Revenues
Revenues
6960370000 USD
CY2019 us-gaap Revenues
Revenues
8233859000 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
7000000 USD
CY2020Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2000000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17219000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16659000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38587000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37015000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P14Y5M15D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M17D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0313
CY2021 sanm Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
29000000 USD
CY2021 sanm Percentageof Face Valueof Receivable Sold
PercentageofFaceValueofReceivableSold
1
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0272
CY2020 sanm Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
16000000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
20000000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
19000000 USD
CY2021 sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
21000000 USD
CY2020 sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
21000000 USD
CY2019 sanm Operating Leases Rent Expense Net Of Sublease Income
OperatingLeasesRentExpenseNetOfSubleaseIncome
26000000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18475000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12602000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8366000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6440000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4155000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11341000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
61379000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5573000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
16973000 USD
CY2021 sanm Percentageof Face Valueof Receivable Sold
PercentageofFaceValueofReceivableSold
1
CY2021 sanm Accounts Receivable Sold During The Period
AccountsReceivableSoldDuringThePeriod
500000000 USD
CY2020 sanm Accounts Receivable Sold During The Period
AccountsReceivableSoldDuringThePeriod
1700000000 USD
CY2021Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
37000000 USD
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
37000000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
15000000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
27000000 USD
CY2019 us-gaap Restructuring Charges
RestructuringCharges
14000000 USD
CY2021 us-gaap Restructuring Charges
RestructuringCharges
15057000 USD
CY2020 us-gaap Restructuring Charges
RestructuringCharges
26783000 USD
CY2019 us-gaap Restructuring Charges
RestructuringCharges
13753000 USD
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
6000000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9000000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
200300000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
96993000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
153696000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
106705000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
103765000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
91923000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
307005000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
200758000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
245619000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
705000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-917000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
868000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
34157000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
9460000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
45910000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4241000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1705000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2747000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-302000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2579000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2961000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-906000 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
46376000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
45929000 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
112000 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1842000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
5689000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38007000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61045000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104104000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000000 USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.12
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000000 USD
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104000000 USD
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.42
CY2020 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
22000000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
127243000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
168570000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
112516000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
111418000 USD
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
24219000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
22684000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
43932000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
49022000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
25494000 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
24545000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
17250000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
15948000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
11534000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
13389000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7677000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6519000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
18336000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other Comprehensive Loss
DeferredTaxAssetsOtherComprehensiveLoss
7637000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other Comprehensive Loss
DeferredTaxAssetsOtherComprehensiveLoss
10793000 USD
CY2021Q4 sanm Lease Deferred Tax Asset
LeaseDeferredTaxAsset
11563000 USD
CY2020Q4 sanm Lease Deferred Tax Asset
LeaseDeferredTaxAsset
10929000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3063000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
115258000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
111127000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
292143000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
342726000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
14775000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
16240000 USD
CY2021Q4 sanm Deferred Tax Liability Branch Operations
DeferredTaxLiabilityBranchOperations
30000000 USD
CY2020Q4 sanm Deferred Tax Liability Branch Operations
DeferredTaxLiabilityBranchOperations
32351000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
1702000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
14258000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0733
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1302
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
11349000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
10781000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2495000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
231822000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
269096000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
235117000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
273470000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
231822000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
269096000 USD
CY2021Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
410000000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1028
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0186
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0059
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.0040
CY2021 sanm Tax Effectof Restructuring Transaction
TaxEffectofRestructuringTransaction
0
CY2020 sanm Tax Effectof Restructuring Transaction
TaxEffectofRestructuringTransaction
0
CY2019 sanm Tax Effectof Restructuring Transaction
TaxEffectofRestructuringTransaction
0.0888
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.0050
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.0131
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.0007
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.0017
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.0006
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.0068
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0101
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0196
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0219
CY2021 sanm Tax Effect On Release Of Foreign Tax Reserves
TaxEffectOnReleaseOfForeignTaxReserves
-0.1443
CY2020 sanm Tax Effect On Release Of Foreign Tax Reserves
TaxEffectOnReleaseOfForeignTaxReserves
-0.0361
CY2019 sanm Tax Effect On Release Of Foreign Tax Reserves
TaxEffectOnReleaseOfForeignTaxReserves
-0.0098
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
66677000 USD
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
60787000 USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1238
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3041
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.4238
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
74612000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6063000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1327000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1731000 USD
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
7349000 USD
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
9907000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
8902000 USD
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
626000 USD
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
20243000 USD
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
3299000 USD
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
655000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
67781000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
74612000 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
66677000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
17000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
40000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
23000000 USD
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1000000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
58000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
68000000 USD
CY2019Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
62000000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268998000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
139713000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
141515000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65318000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69041000 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69129000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1766000 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1752000 shares
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2549000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67084000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70793000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71678000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.05
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.01
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.97
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7500000 shares
CY2021Q4 sanm Stock Options And Unvested Restricted Stock Units Outstanding
StockOptionsAndUnvestedRestrictedStockUnitsOutstanding
3700000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3800000 shares
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 USD
CY2021 sanm Shares Repurchased
SharesRepurchased
1500000 shares
CY2020 sanm Shares Repurchased
SharesRepurchased
6400000 shares
CY2019 sanm Shares Repurchased
SharesRepurchased
300000 shares
CY2021 sanm Share Repurchases
ShareRepurchases
54000000 USD
CY2020 sanm Share Repurchases
ShareRepurchases
166000000 USD
CY2019 sanm Share Repurchases
ShareRepurchases
7000000 USD
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
81000000 USD
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
207000 shares
CY2021 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
286000 shares
CY2020 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
398000 shares
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000000 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13000000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
76120000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
85343000 USD
CY2021Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-14305000 USD
CY2020Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-22202000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
21125000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
28255000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
40690000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34886000 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
8000000 USD
CY2021 sanm Reportable Segment Revenue Percentage
ReportableSegmentRevenuePercentage
0.80
CY2021 us-gaap Revenues
Revenues
6756643000 USD
CY2020 us-gaap Revenues
Revenues
6960370000 USD
CY2019 us-gaap Revenues
Revenues
8233859000 USD
CY2021 us-gaap Gross Profit
GrossProfit
551805000 USD
CY2020 us-gaap Gross Profit
GrossProfit
525707000 USD
CY2019 us-gaap Gross Profit
GrossProfit
591938000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
109656000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114218000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
116949000 USD
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
81854000 USD
CY2020 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
51075000 USD
CY2019 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
112408000 USD
CY2021 sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.527
CY2020 sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.555
CY2019 sanm Percentage Of Net Sales Represented By Ten Largest Customers
PercentageOfNetSalesRepresentedByTenLargestCustomers
0.542
CY2021 sanm Number Of Customers Representing More Than10 Of Net Sales
NumberOfCustomersRepresentingMoreThan10OfNetSales
1
CY2020 sanm Number Of Customers Representing More Than10 Of Net Sales
NumberOfCustomersRepresentingMoreThan10OfNetSales
1
CY2019 sanm Number Of Customers Representing More Than10 Of Net Sales
NumberOfCustomersRepresentingMoreThan10OfNetSales
1
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
532985000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
559242000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
30844000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34976000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
26235000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
30844000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
34976000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
26235000 USD
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3303000 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.33
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y2M15D
CY2018Q3 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
97913000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1843000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.09
CY2019 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
1993000 shares
CY2019 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
29.46
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3153000 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
27.82
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y3M18D
CY2019Q3 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
102720000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1340000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
32.51
CY2020 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
1925000 shares
CY2020 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
28.62
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2568000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.67
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y2M23D
CY2020Q4 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
71571000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1529000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
34.26
CY2021 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelled
1143000 shares
CY2021 sanm Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested And Cancelled Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndCancelledWeightedAverageGrantDateFairValue
29.27
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2954000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
32.21
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y2M23D
CY2021Q4 sanm Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
Sharebasedcompensationarrangementsbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue
113591000 USD
CY2021Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestNumber
2629000 shares
CY2021Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageGrantDateFairValue
32.10
CY2021 sanm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested And Expected To Vest Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedAndExpectedToVestWeightedAverageRemainingContractualTerm
P1Y2M1D
CY2021Q4 sanm Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Nonvested And Expected To Vest Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNonvestedAndExpectedToVestAggregateIntrinsicValue
101111000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
32000000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
43000000 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
29000000 USD

Files In Submission

Name View Source Status
0000897723-21-000028-index-headers.html Edgar Link pending
0000897723-21-000028-index.html Edgar Link pending
0000897723-21-000028.txt Edgar Link pending
0000897723-21-000028-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sanm-20211002.htm Edgar Link pending
sanm-20211002.xsd Edgar Link pending
sanm-20211002_cal.xml Edgar Link unprocessable
sanm-20211002_def.xml Edgar Link unprocessable
sanm-20211002_g1.jpg Edgar Link pending
sanm-20211002_htm.xml Edgar Link completed
sanm-20211002_lab.xml Edgar Link unprocessable
sanm-20211002_pre.xml Edgar Link unprocessable
sanm_10022021xex141x10k.htm Edgar Link pending
sanm_10022021xex211x10k.htm Edgar Link pending
sanm_10022021xex231x10k.htm Edgar Link pending
sanm_10022021xex311x10k.htm Edgar Link pending
sanm_10022021xex312x10k.htm Edgar Link pending
sanm_10022021xex321x10k.htm Edgar Link pending
sanm_10022021xex322x10k.htm Edgar Link pending
Show.js Edgar Link pending